Most sold healthcare stocks in Q1 2026
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q1 2026 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include ASTRAZENECA PLC-SPONS ADR (AZN), AGILON HEALTH INC (AGL), EXACT SCIENCES CORP (EXAS), AVIDITY BIOSCIENCES INC (RNA). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC-SPONS ADR | -480,020,710 | -$38.8B | 11 | 4 | 42 | 1264 | 62 |
| AGL | AGILON HEALTH INC | -352,467,553 | -$237.3M | 1 | 0 | 2 | 185 | 3 |
| EXAS | EXACT SCIENCES CORP | -143,310,201 | -$14.1B | 1 | 2 | 3 | 672 | 8 |
| RNA | AVIDITY BIOSCIENCES INC | -125,768,244 | -$8.8B | 0 | 0 | 0 | 329 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | -102,567,239 | -$1.5B | 0 | 0 | 0 | 257 | 1 |
| MNMD | MIND MEDICINE MINDMED INC | -54,009,141 | -$721.8M | 0 | 0 | 0 | 192 | 1 |
| ATXS | ASTRIA THERAPEUTICS INC | -52,765,381 | -$635.5M | 0 | 0 | 0 | 137 | 0 |
| VTYX | VENTYX BIOSCIENCES INC | -48,233,423 | -$426.5M | 1 | 0 | 0 | 135 | 1 |
| APLT | APPLIED THERAPEUTICS INC | -39,127,515 | -$3.1M | 0 | 0 | 0 | 51 | 0 |
| XLO | XILIO THERAPEUTICS INC | -37,821,734 | -$19.0M | 0 | 0 | 1 | 35 | 1 |
| CDTX | CIDARA THERAPEUTICS INC | -31,072,157 | -$6.6B | 0 | 0 | 0 | 237 | 0 |
| GUTS | FRACTYL HEALTH INC | -29,713,540 | -$190.1M | 19 | 14 | 27 | 31 | 82 |
| RPTX | REPARE THERAPEUTICS INC | -25,043,591 | -$63.2M | 0 | 0 | 0 | 45 | 0 |
| RLYB | RALLYBIO CORP | -23,904,919 | -$19.9M | 0 | 0 | 0 | 44 | 0 |
| EW | EDWARDS LIFESCIENCES CORP | -23,112,204 | -$3.9B | 107 | 451 | 439 | 116 | 1250 |
| GSK | GSK PLC-SPON ADR | -21,976,713 | $1.2B | 137 | 313 | 367 | 85 | 1007 |
| ANEB | ANEBULO PHARMACEUTICALS INC | -21,772,995 | -$91.1M | 0 | 0 | 0 | 18 | 0 |
| LIFWW | MSP RECOVERY INC -27 | -20,571,487 | -$65 | 0 | 0 | 0 | 3 | 0 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -19,484,863 | -$97.0M | 93 | 232 | 194 | 65 | 641 |
| TMO | THERMO FISHER SCIENTIFIC INC | -18,242,980 | -$13.7B | 163 | 956 | 1075 | 232 | 2547 |
| QIPT | QUIPT HOME MEDICAL CORP | -17,429,062 | -$42.7M | 0 | 0 | 0 | 68 | 0 |
| SNY | SANOFI-ADR | -16,742,957 | -$577.0M | 104 | 292 | 209 | 107 | 725 |
| ATOS | ATOSSA THERAPEUTICS INC | -15,803,079 | -$9.3M | 0 | 0 | 0 | 63 | 0 |
| HBIO | HARVARD BIOSCIENCE INC | -15,300,106 | -$8.0M | 0 | 0 | 3 | 60 | 3 |
| MODD | MODULAR MEDICAL INC | -14,735,208 | -$5.6M | 0 | 0 | 0 | 30 | 0 |
| BDX | BECTON DICKINSON AND CO | -12,681,766 | -$2.4B | 134 | 571 | 511 | 194 | 1442 |
| CGC | CANOPY GROWTH CORP | -11,392,604 | -$124.2M | 34 | 38 | 44 | 30 | 217 |
| ASND | ASCENDIS PHARMA A/S - ADR | -10,251,038 | -$747.7M | 34 | 106 | 98 | 67 | 261 |
| SMLR | SEMLER SCIENTIFIC INC | -9,987,284 | -$152.0M | 0 | 0 | 0 | 107 | 0 |
| AVNS | AVANOS MEDICAL INC | -9,243,347 | -$987.0M | 30 | 69 | 70 | 43 | 252 |
| RVPH | REVIVA PHARMACEUTICALS HOLDI | -7,901,957 | -$2.2M | 0 | 0 | 0 | 42 | 1 |
| HLN | HALEON PLC-ADR | -7,432,314 | -$285.4M | 87 | 210 | 173 | 64 | 611 |
| ABVX | ABIVAX SA-ADR | -6,893,791 | -$2.1B | 52 | 109 | 74 | 44 | 249 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -6,727,580 | -$1.6B | 124 | 380 | 476 | 161 | 1235 |
| SYBX | SYNLOGIC INC | -6,655,036 | -$7.5M | 0 | 0 | 1 | 22 | 2 |
| SLNO | SOLENO THERAPEUTICS INC | -6,567,433 | -$889.5M | 44 | 90 | 68 | 61 | 222 |
| NVNO | ENVVENO MEDICAL CORP | -6,256,134 | -$1.9M | 0 | 0 | 0 | 34 | 0 |
| AUTL | AUTOLUS THERAPEUTICS PLC | -5,685,505 | -$83.0M | 9 | 23 | 28 | 13 | 83 |
| TNYA | TENAYA THERAPEUTICS INC | -5,669,115 | -$4.9M | 27 | 32 | 17 | 21 | 102 |
| CHE | CHEMED CORP | -5,295,707 | -$814.3M | 54 | 176 | 186 | 70 | 482 |
| GOSS | GOSSAMER BIO INC | -5,188,517 | -$462.2M | 44 | 70 | 48 | 54 | 180 |
| GPCR | STRUCTURE THERAPEUTICS INC | -4,477,990 | -$1.6B | 38 | 70 | 59 | 39 | 192 |
| IOBT | IO BIOTECH INC | -4,456,602 | -$4.6M | 2 | 2 | 5 | 12 | 12 |
| TVGN | TEVOGEN BIO HOLDINGS INC | -3,945,755 | -$1.3M | 0 | 0 | 0 | 50 | 0 |
| IMAB | I-MAB-SPONSORED ADR | -3,943,101 | -$60.3M | 8 | 15 | 14 | 18 | 47 |
| QNCX | QUINCE THERAPEUTICS INC | -3,666,892 | -$58.0M | 12 | 7 | 11 | 38 | 39 |
| CODX | CO-DIAGNOSTICS INC | -3,590,383 | -$610.2K | 0 | 0 | 0 | 25 | 0 |
| ADIL | ADIAL PHARMACEUTICALS INC | -3,380,198 | -$729.6K | 0 | 0 | 0 | 22 | 0 |
| INTS | INTENSITY THERAPEUTICS INC | -3,264,898 | -$1.3M | 0 | 0 | 0 | 33 | 0 |
| HITI | HIGH TIDE INC | -3,242,543 | -$11.5M | 12 | 10 | 15 | 14 | 50 |